Macrogenics (MGNX) EBT Margin (2012 - 2026)
Macrogenics' EBT Margin came in at -212.12% for Q2 2026, up 408.24 percentage points from -620.35% a year earlier but down 27.63 percentage points from the prior quarter.
Powered by 
Analysis
Macrogenics (MGNX) EBT Margin (2012 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Macrogenics reported EBT Margin of -63.27%, down 34.29 percentage points year-over-year; for FY2025, it was -50.36%, down 6.34 percentage points from FY2024.
- EBT Margin carries a five-year change of +74.60 percentage points (FY2020 to FY2025).
- Going back by year, EBT Margin was -44.03% in FY2024 (-28.61 pp), -15.42% in FY2023 (+63.40 pp), -78.82% in FY2022 (+183.03 pp) and -261.85% in FY2021 (-136.89 pp).
- The five-year range for quarterly EBT Margin is -620.35% (Q2 2025) to 50.86% (Q3 2024).
- Year-over-year, EBT Margin has increased for three consecutive quarters, with an average year-over-year change of +188.81 percentage points over the last eight quarters.
- The fastest year-over-year change in EBT Margin over five years came in Q1 2023 (a gain of 440.74 percentage points), and the weakest in Q4 2023 (a drop of 476.78 percentage points).
- Business Quant data shows MGNX's EBT Margin at -184.49% (Q1 2026), -36.22% (Q4 2025) and 23.09% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Macrogenics | 258.40 Mn | -59.37 Mn | - | -212.12% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -212.12% |
| Mar 31, 2026 | -184.49% |
| Dec 31, 2025 | -36.22% |
| Sep 30, 2025 | 23.09% |
| Jun 30, 2025 | -620.35% |
| Mar 31, 2025 | -323.79% |
| Dec 31, 2024 | -74.80% |
| Sep 30, 2024 | 50.86% |
| Jun 30, 2024 | -515.55% |
| Mar 31, 2024 | -602.84% |
| Dec 31, 2023 | -460.39% |
| Sep 30, 2023 | -341.46% |
| Jun 30, 2023 | -348.17% |
| Mar 31, 2023 | -159.54% |
| Dec 31, 2022 | 16.39% |
| Sep 30, 2022 | -59.80% |
| Jun 30, 2022 | -160.76% |
| Mar 31, 2022 | -600.29% |
| Dec 31, 2021 | -411.65% |
| Sep 30, 2021 | -338.32% |
API Access
Macrogenics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=MGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "MGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=MGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();